Cargando…
EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors
Low doses of μ-opioid receptor (MOR) agonists rapidly ameliorate symptoms in treatment-resistant obsessive–compulsive disorder (OCD) patients (10–50% of OCD patients). However, the utility of MOR agonists is limited by their safety liabilities. We developed a novel MOR partial agonist (EPD1540) that...
Autores principales: | Youngblood, Beth, Medina, Julio C., Gehlert, Donald R., Schwartz, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349350/ https://www.ncbi.nlm.nih.gov/pubmed/37457777 http://dx.doi.org/10.3389/fpsyt.2023.1170541 |
Ejemplares similares
-
Validation and Factor Analysis of the Obsessive Compulsive Drinking Scale (OCDS) in the Chinese Population
por: Wang, Hongxuan, et al.
Publicado: (2021) -
Obsessive–Compulsive Personality Symptoms Predict Poorer Response to Gamma Ventral Capsulotomy for Intractable OCD
por: Copetti, Maria Eugênia, et al.
Publicado: (2020) -
Editorial: Obsessive-compulsive disorder (OCD) across the lifespan: Current diagnostic challenges and the search for personalized treatment
por: Shavitt, Roseli G., et al.
Publicado: (2022) -
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
por: Del Casale, Antonio, et al.
Publicado: (2019) -
Screening for Perinatal OCD: A Comparison of the DOCS and the EPDS
por: Fairbrother, Nichole, et al.
Publicado: (2021)